Cargando…
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage
Reprograming of cellular metabolism is a hallmark of cancer. The metabolic alterations in cancer cells is not only defined by series of genetic mutations, but also reflecting the crosstalk between cancer cells and other factors in the microenvironment. Altering metabolism allows cancer cells to over...
Autores principales: | Pham, Khoa, Poore, Brad, Hanaford, Allison, Maxwell, Micah J, Sweeney, Heather, Parthasarathy, Akhila, Alt, Jesse, Rais, Rana, Slusher, Barbara S, Eberhart, Charles G, Raabe, Eric H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255443/ http://dx.doi.org/10.1093/noajnl/vdab070.060 |
Ejemplares similares
-
FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE
por: Pham, Khoa, et al.
Publicado: (2021) -
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways
por: Pham, Khoa, et al.
Publicado: (2022) -
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019) -
OTME-14. TGF-beta signaling in microtube formation of glioblastoma
por: Storevik, Simon, et al.
Publicado: (2021) -
ATRT-17. TARGETING GLUTAMINE METABOLISM LOWERS METHYLATION POTENCIALS IN AT/RT AND SYNERGIZE WITH TAZEMETOSTAT
por: Nakata, Satoshi, et al.
Publicado: (2020)